Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

BRAF inhibitors promote intermediate BRAF(V600E) conformations and binary interactions with activated RAS.

Röck R, Mayrhofer JE, Torres-Quesada O, Enzler F, Raffeiner A, Raffeiner P, Feichtner A, Huber RG, Koide S, Taylor SS, Troppmair J, Stefan E.

Sci Adv. 2019 Aug 14;5(8):eaav8463. doi: 10.1126/sciadv.aav8463. eCollection 2019 Aug.

2.

The many faces of compartmentalized PKA signalosomes.

Torres-Quesada O, Mayrhofer JE, Stefan E.

Cell Signal. 2017 Sep;37:1-11. doi: 10.1016/j.cellsig.2017.05.012. Epub 2017 May 18. Review.

3.

Gpr161 anchoring of PKA consolidates GPCR and cAMP signaling.

Bachmann VA, Mayrhofer JE, Ilouz R, Tschaikner P, Raffeiner P, Röck R, Courcelles M, Apelt F, Lu TW, Baillie GS, Thibault P, Aanstad P, Stelzl U, Taylor SS, Stefan E.

Proc Natl Acad Sci U S A. 2016 Jul 12;113(28):7786-91. doi: 10.1073/pnas.1608061113. Epub 2016 Jun 28.

4.

Corrigendum: Impact of kinase activating and inactivating patient mutations on binary PKA interactions.

Röck R, Mayrhofer JE, Bachmann V, Stefan E.

Front Pharmacol. 2015 Sep 24;6:214. doi: 10.3389/fphar.2015.00214. eCollection 2015.

5.

Impact of kinase activating and inactivating patient mutations on binary PKA interactions.

Röck R, Mayrhofer JE, Bachmann V, Stefan E.

Front Pharmacol. 2015 Aug 18;6:170. doi: 10.3389/fphar.2015.00170. eCollection 2015. Erratum in: Front Pharmacol. 2015;6:214.

6.

In-vivo detection of binary PKA network interactions upon activation of endogenous GPCRs.

Röck R, Bachmann V, Bhang HE, Malleshaiah M, Raffeiner P, Mayrhofer JE, Tschaikner PM, Bister K, Aanstad P, Pomper MG, Michnick SW, Stefan E.

Sci Rep. 2015 Jun 23;5:11133. doi: 10.1038/srep11133.

Supplemental Content

Loading ...
Support Center